International Clinical Trial: A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07363694) titled 'A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease' on Jan. 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Pfizer

Condition: Moderate to Severe Chronic Obstructive Pulmonary Disease

Intervention: Drug: PF-07275315 dose 1 Drug: PF-07275315-dose 2 Drug: Placebo

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: Januar...